Cargando…
Mechanisms of adverse effects of anti-VEGF therapy for cancer
Advances in understanding the role of vascular endothelial growth factor (VEGF) in normal physiology are giving insight into the basis of adverse effects attributed to the use of VEGF inhibitors in clinical oncology. These effects are typically downstream consequences of suppression of cellular sign...
Autores principales: | Kamba, T, McDonald, D M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359962/ https://www.ncbi.nlm.nih.gov/pubmed/17519900 http://dx.doi.org/10.1038/sj.bjc.6603813 |
Ejemplares similares
-
The role of the VEGF-C/VEGFR-3 axis in cancer progression
por: Su, J-L, et al.
Publicado: (2007) -
Targeted anti-vascular therapies for ovarian cancer: current evidence
por: Hall, M, et al.
Publicado: (2013) -
The place of VEGF inhibition in the current management of renal cell carcinoma
por: Nathan, P, et al.
Publicado: (2006) -
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010) -
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
por: Muniyandi, Anbukkarasi, et al.
Publicado: (2023)